Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Tiger Investment Representatives
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Astellas Pharma, Inc.

14.90
0.0000
Volume:5.00
Turnover:78.89
Market Cap:27.74B
PE:200.40
High:14.90
Open:14.90
Low:14.90
Close:14.90
52wk High:14.90
52wk Low:8.41
Shares:1.86B
Float Shares:1.73B
Volume Ratio:0.01
T/O Rate:NaN%
Dividend:0.50
Dividend Rate:3.38%
EPS(TTM):0.0744
EPS(LYR):0.0628
ROE:19.82%
ROA:7.38%
PB:2.47
PE(LYR):237.11

Loading ...

OverviewCompanyNewsFilings

Goldman Sachs Remains a Buy on Astellas Pharma (ALPMF)

TIPRANKS
·
Feb 05

Bernstein Reaffirms Their Hold Rating on Astellas Pharma (ALPMF)

TIPRANKS
·
Feb 04

Daiwa Sticks to Their Sell Rating for Astellas Pharma (ALPMF)

TIPRANKS
·
Jan 29

Macquarie Sticks to Their Buy Rating for Astellas Pharma (ALPMF)

TIPRANKS
·
Jan 26

Citi Sticks to Its Hold Rating for Astellas Pharma (ALPMF)

TIPRANKS
·
Jan 20

Analysts Have Conflicting Sentiments on These Healthcare Companies: Eli Lilly & Co (LLY), Spyre Therapeutics (SYRE) and Astellas Pharma (OtherALPMF)

TIPRANKS
·
Jan 20

Bernstein Reaffirms Their Hold Rating on Astellas Pharma (ALPMF)

TIPRANKS
·
Oct 10, 2025

Analyst Rate

 
 
 
 

Corporate Actions

Financial Report Announcement
Apr 25, 2024
Financial Report Announcement
Feb 05, 2024
Financial Report Announcement
Nov 01, 2023
Ex-dividend Date
Sep 28, 2023 Dividend Per Share 35 JPY
Financial Report Announcement
Aug 01, 2023

Dividend History

Ex-DateDividend
2019-03-2719
2019-09-2720
2020-03-3020
2020-09-2921
2021-03-3021

Valuation Analysis

 
Current
 
Sector Average
 
Historical Percentile
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.